Olympus adds EndoRobotics tools to endoscopy portfolio

Olympus has signed an exclusive global distribution agreement with EndoRobotics for robot-assisted endoscopic technologies. The technologies will be distributed as part of Olympus’ EndoTherapy portfolio.

The agreement is focused on complex endoscopic procedures, including endoscopic submucosal dissection. ESD is used to remove diseased tissue in the gastrointestinal tract without organ resection.

Under the agreement, the companies plan to launch first in the U.S. Additional regional rollouts are expected to follow, subject to regulatory requirements.

EndoRobotics’ technologies are designed to support precision, control, and efficiency in complex endoscopic procedures, according to Olympus. The company said the tools are intended to support broader adoption of advanced endoscopic therapy.

Olympus said the agreement fits its strategy in endoluminal robotics. The company described the deal as part of its effort to bring new technologies for complex endoscopic therapy to global markets while continuing longer-term work on platform innovation.